Similar articles

• CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells.

  Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ. Draffin JE, et al. Cancer Res. 2004 Aug 15;64(16):5702-11. doi: 10.1158/0008-5472.CAN-04-0389. Cancer Res. 2004. PMID: 15313910
• Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.

  Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ. Balic M, et al. Clin Cancer Res. 2006 Oct 1;12(19):5615-21. doi: 10.1158/1078-0432.CCR-06-0169. Clin Cancer Res. 2006. PMID: 17020963
• Cellular interactions in the tropism of prostate cancer to bone.

  Sikes RA, Nicholson BE, Koeneman KS, Edlund NM, Bissonette EA, Bradley MJ, Thalmann GN, Cecchini MG, Pienta KJ, Chung LW. Sikes RA, et al. Int J Cancer. 2004 Jul 1;110(4):497-503. doi: 10.1002/ijc.20153. Int J Cancer. 2004. PMID: 15122581
• IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction.

  Chen C, Zhang Q, Liu S, Parajuli KR, Qu Y, Mei J, Chen Z, Zhang H, Khismatullin DB, You Z. Chen C, et al. Prostate. 2015 Jun;75(8):883-95. doi: 10.1002/pros.22971. Epub 2015 Feb 14. Prostate. 2015. PMID: 25683512 Free PMC article.
• Bone marrow cells in the 'pre-metastatic niche': within bone and beyond.

  Kaplan RN, Psaila B, Lyden D. Kaplan RN, et al. Cancer Metastasis Rev. 2006 Dec;25(4):521-9. doi: 10.1007/s10555-006-9036-9. Cancer Metastasis Rev. 2006. PMID: 17186383 Review.